Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | hypothetical protein, conserved | 0.0023 | 0.5 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0023 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0023 | 0.5 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0023 | 0.5 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0023 | 0.5 | 0.5 |
Treponema pallidum | mcbG protein | 0.0023 | 0.5 | 0.5 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0023 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 162.9 uM | Inhibition of beta amyloid-ABAD interaction by ELISA | ChEMBL. | 16781151 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.